StreetAlpha.app
Home › Stocks › ANIK

Anika Therapeutics, Inc. (ANIK)

$12.85
▼ −0.54%
LAST CLOSE · NOV 17

Anika Therapeutics makes hyaluronic acid products for osteoarthritis pain relief and orthopedic repair, sold to medical partners and clinics. It last closed at $12.85 on Nov 17, down 0.54% on the day. ANIK last reported earnings on Fri, Nov 6, 2026.

AI Auto Pilots
Is ANIK in one of our four AI portfolios? Sign in free to see

Key Stats

Last 12 months
Results
Revenue
$123.4M
+9.4% vs a year ago
Net income
−$1.8M
−1.4% margin
EPS (diluted)
−$0.13
Free cash flow
$2.3M
1.9% margin
Valuation
Market cap
$172.1M
13.4M shares
P/E
–
No P/E while losing money
Price to sales
1.4
Market cap over revenue
Dividend yield
None
No dividend in 12 months
Balance sheet
Cash & equivalents
$45.0M
At Sep 30
Shareholder equity
$137.6M
Buybacks
$15.1M
Last 12 months
Fiscal year endsDecember
ExchangeNasdaq
Financials history
FY2021: $147.8M$147.8MFY2021FY2022: $113.8M$113.8MFY2022FY2023: $120.8M$120.8MFY2023FY2024: $119.9M$119.9MFY2024FY2025: $112.8M$112.8MFY2025

From ANIK's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Nov 6). Last 12 months adds up the four latest quarters.

Last report
Nov 6
2026 · Before the open (BMO)
Reported EPS
$0.29
vs $0.42 est. · miss
Year-ago EPS
—
Not on file
Options-implied move
±13.4%
Priced in before that report
Analyst consensus
1 Buy
1 firm · not enough for a consensus
Loading…

Analyst Ratings & Price Targets

Analyst Ratings →
Ratings · 90 days
1 Buy
1firm
1 Buy0 Hold0 Sell
Only 1 firm rated ANIK in the past 90 days, not enough for a consensus
Average 12-month target
$17.00
▲ 32.3% upside

Based on 1 analyst who set a price target on ANIK in the past 90 days. The average target is $17.00, with a high of $17.00 and a low of $17.00, compared with the last close of $12.85.

Low $17.00Avg $17.00High $17.00
Blue marker: last close $12.85
Highest target$17.00
Average target$17.00
Lowest target$17.00
Latest rating changes
B. Riley SecuritiesTarget lowered
Nov 16Buy$23 → $17
B. Riley SecuritiesAssumed coverage
Sep 18Buy$23
B. Riley SecuritiesMaintained
Jul 30Buy$21
DateFirmActionRatingPrice target
Nov 16B. Riley SecuritiesTarget loweredBuy$23 → $17
Sep 18B. Riley SecuritiesAssumed coverageBuy$23
Jul 30B. Riley SecuritiesMaintainedBuy$21
Loading…

Technical Analysis

ANIK · as of the Nov 17 close · updated after every close
Pullback inside a longer uptrend, oversold

The stock is 39% below its 20 day and 50% below its 50 day average. It is 28% below its 200 day average, so the longer trend is down. Momentum is weak (RSI 22), oversold. The nearest support is the Pivot at $12.80, and the nearest resistance the Pivot R1 at $13.19.

Short trendBearish
Long trendBullish
MomentumWeak
StretchOversold
VolatilityHigh, 7.9%/day
Key levels
$22.8852 week high+78.1%
$19.3350 day average+50.4%
$18.92100 day average+47.2%
$17.9120 day average+39.4%
$16.46200 day average+28.1%
$15.07Swing high (Jun 4)+17.3%
$13.19Pivot R1+2.6%
$12.85Last close
$12.80Pivot−0.4%
$12.45Pivot S1−3.1%
$9.0152 week low−29.9%
Indicators
RSI (14)22.26Oversold below 30Oversold
MACD-1.99Below its signal lineBearish
Stochastic2.5Near the bottom of its rangeOversold
ADX (14)40.7Strong downtrend
Williams %R-95.2Oversold below −80, overbought above −20Oversold
CCI (20)-105.3Oversold below −100, overbought above 100Oversold
Rate of change−33.9%Change over 10 sessionsBearish
ATR (14)$1.02Typical daily range, 7.9% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
What happened before, for ANIK

What happened before

See how ANIK did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.

November seasonalityHow ANIK usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

Seasonality

How ANIK has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2006.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D

No whale options trades in ANIK in the last 90 days.

Loading…

See today’s whale options flow across the market →

ANIK Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Neutral
Strongly bearishNeutralStrongly bullish
  • ●62 buying vs 67 selling
  • ▼Held by funds -1.6 pts
  • ▲Funds holding +6
  • ▲Superinvestors: 3 added, 1 cut
  • ●Put/call not meaningful
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holdingHeld by funds %
Q3 2026This quarterLast quarterChange
Funds holding139133+4.5%
In funds' top 1000–
Held by funds90.2%91.8%−1.6 pts
New / increased19 / 4318 / 48−6.1%
Reduced / sold out54 / 1339 / 12+31.4%
Put/call ratio–––
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See ANIK institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

AI Auto Pilots

Paper trading

StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether ANIK is in one of them and how their past ANIK trades turned out.

ANIK in the AI portfolios
Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered ANIK in an article yet. Here's the latest on the wider market.

ANIK Congress Trades

All congress trades →
Trades, 12 months
0
Buys
0
Sells
0
People
0
Last filed Mar 5
Who traded ANIK · since 2020
Latest 2 filings
$1K – $15KTraded Mar 2, 2020Filed Mar 5, 2021
$15K – $50KTraded Feb 26, 2020Filed Mar 5, 2021
PersonTypeAmountTradedFiledDelay
Tom MalinowskiD · NJBuy$1K – $15KMar 2, 2020Mar 5, 2021368 d
Tom MalinowskiD · NJBuy$15K – $50KFeb 26, 2020Mar 5, 2021373 d

Members of Congress and senior officials report trades up to 45 days later, as dollar ranges. Filings show a trade happened, not why. Not investment advice.

About Anika Therapeutics

Anika Therapeutics is a medical device company based in Bedford, Massachusetts. It makes products from hyaluronic acid, a substance naturally found in the body. Its main lines are injections for relieving pain from osteoarthritis and orthopedic products used to repair cartilage, bone and tendons. It sells to medical device partners that resell its products, and directly to clinics, surgeons and distributors, including customers outside the United States.

Headquarters
Bedford, MA